Key facts
- Virchow Medical’s last known valuation is $14.8M (Mar 2026).
- It has raised $4.1M across 1 recorded rounds; the latest was Seed Round ($4.1M) in Mar 2026.
- Notable investors include Cerberus Ventures, EvoNexus.
- Virchow Medical has filed 1 Form D with the SEC, most recently Apr 2026 ($4.1M sold to 27 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Virchow Medical
Funding rounds
1 roundsAbout Virchow Medical
Developer of a precision diagnostics and biopsy-based specimen management system designed to improve the collection, handling, and analysis of clinical samples for medical research and patient care. The company offers advanced liquid companion specimen technologies, integrated clinical data, and a secure specimen management vault, enabling pathologists, oncologists, clinical laboratories, and research organizations to enhance accuracy, traceability, and efficiency in diagnostic and genomic testing workflows.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2023
- Employees
- 7
- Website
- virchowmed.com/
- Ownership
- Privately Held (backing)
Virchow Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Virchow Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Virchow Medical in its N-PORT filings yet. We sweep new filings monthly.